York Bridge Wealth Partners, LLC Corcept Therapeutics Inc Transaction History

York Bridge Wealth Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$10.03 - $15.71 $6,449 - $10,101	-643 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $7,846 - $11,947	-695 Reduced 51.94%	643 $9,000
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $269 - $344	22 Added 1.67%	1,338 $18,000
Q2 2018 Aug 10, 2018	BUY	$15.3 - $19.69 $4,528 - $5,828	296 Added 29.02%	1,316 $21,000
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $2,305 - $4,029	158 Added 18.33%	1,020 $17,000

Q4 2017 Feb 12, 2018	BUY	$15.77 - $20.72 $13,593 - $17,860	862	862 $15,000

316

93.8M

2.02M

3.24M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.27B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.